UNICA IRIS Institutional Research Information System

SERPE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 99.777
NA - Nord America 4.862
AS - Asia 739
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
AF - Africa 3
Totale 105.408
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 98.342
US - Stati Uniti d'America 4.826
CN - Cina 526
UA - Ucraina 495
SE - Svezia 345
DE - Germania 207
GB - Regno Unito 137
SG - Singapore 133
FI - Finlandia 129
FR - Francia 47
CA - Canada 32
KR - Corea 22
BE - Belgio 18
IR - Iran 16
RU - Federazione Russa 16
IN - India 13
BR - Brasile 11
VN - Vietnam 8
EU - Europa 7
NL - Olanda 7
AU - Australia 6
ES - Italia 6
TR - Turchia 6
RS - Serbia 5
HK - Hong Kong 4
IE - Irlanda 4
RO - Romania 4
AR - Argentina 3
BG - Bulgaria 3
MX - Messico 3
PH - Filippine 3
AT - Austria 2
CH - Svizzera 2
LT - Lituania 2
PL - Polonia 2
TH - Thailandia 2
ZA - Sudafrica 2
AM - Armenia 1
EG - Egitto 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 105.408
Salva come PNG Salva come JPEG
Città #
Cagliari 96.723
Uta 1.343
Woodbridge 599
Fairfield 576
Houston 398
Chandler 390
Ann Arbor 316
Jacksonville 284
Nyköping 268
Ashburn 267
Boardman 250
Wilmington 249
Seattle 236
Dearborn 171
Cambridge 168
Beijing 90
Nanjing 85
Boston 68
Singapore 67
Shanghai 54
Helsinki 52
Santa Clara 51
New York 49
San Diego 44
Nanchang 35
Redwood City 32
Milan 29
Changsha 27
Guangzhou 25
Toronto 23
Hebei 22
Shenyang 21
Tianjin 20
Jinan 18
Brussels 16
London 16
Verona 16
Norwalk 15
Seoul 15
Los Angeles 14
Mountain View 14
Orange 14
Auburn Hills 13
Zhengzhou 11
Jiaxing 10
Rome 10
Sassari 10
Wuhan 9
Dong Ket 8
Nürnberg 7
San Mateo 7
Augusta 6
Bielefeld 6
Hangzhou 6
Hefei 6
Munich 6
Winston-Salem 6
Atlanta 5
Leawood 5
Phoenix 5
Pune 5
Bloomington 4
Dublin 4
Fuzhou 4
Halle 4
Hong Kong 4
Kunming 4
Ningbo 4
Redmond 4
Saint Petersburg 4
Tabriz 4
Taizhou 4
Turin 4
Washington 4
Borås 3
Cedar Knolls 3
Edmonton 3
Granada 3
Millbury 3
Monmouth Junction 3
Rockville 3
Shenzhen 3
Tempe 3
Amsterdam 2
Berlin 2
Capoterra 2
Carolina 2
Costa Mesa 2
Council Bluffs 2
Curno 2
Espoo 2
Federal 2
Forlì 2
Frankfurt am Main 2
Haikou 2
Kilburn 2
Ladispoli 2
Las Piñas 2
Monza 2
Muenster 2
Totale 103.424
Salva come PNG Salva come JPEG
Nome #
High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts 4.786
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.621
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.345
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.231
Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation 3.146
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.850
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 2.689
Positive effects of Nordic Walking on anthropometric and metabolic variables in women with type 2 diabetes mellitus 2.619
Antimicrobial sulfonamides inhibit Herpesvirus 8 latency by impairing the MDM2-p53 complex formation 2.578
Sulfonamide compounds inhibit latent Human Herpesvirus 8 replication by interfering with MDM2-p53 complex formation 2.446
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.338
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 2.289
null 2.211
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.115
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.112
Validation of the CAchexia SCOre (CASCO). Staging cancer patients: The use of miniCASCO as a simplified tool 1.992
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 1.990
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 1.988
null 1.987
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.792
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.711
null 1.699
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.664
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.644
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.618
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.608
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.604
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia 1.579
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects 1.524
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.476
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.450
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.419
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.403
null 1.362
Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children 1.315
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.239
null 1.063
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 770
null 768
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 747
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 740
Current medications for cancer cachexia 740
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 723
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 723
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 721
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 717
null 709
Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity 695
null 694
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 677
Cancer cachexia: Physical activity and muscle force in tumour-bearing rats 665
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 661
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 636
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 630
The cachexia score (CASCO): a new tool for staging cachectic cancer patients 626
Muscle wasting in cancer and ageing: Cachexia versus sarcopenia 624
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 620
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 583
null 572
Megestrol acetate: Its impact on muscle protein metabolism supports its use in cancer cachexia 541
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 512
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 503
Antioxidant therapy for the treatment of oxidative stress associated to cancer and cancer-related anorexia/cachexia 476
Phase II study with antioxidants, both in the diet and supplemented pharmaco-nutritional support, progestagen and anti-cox-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 469
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 468
null 465
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 463
null 450
Prevention of head and neck squamous cell carcinoma. Integrated treatment approach with diet, pharmaco-nutritional support, antioxidants, and cis-retinoic acid. A phase II study. 443
Phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS). and oxidative stress (OS) 442
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress 441
Correlation between both serum osteopontin/osteonectin and bone remodelling parameters, inflammatory/metabolic variables and survival in metastatic cancer patients with tumors at different sites 420
null 413
Prevention of head and neck squamous cell carcinoma. integrated treatment approach with diet, pharmaco-nutritional support, antioxidants (and anti-COX-2): preliminary results of a phase II study 397
An innovative approach to CACS 395
Effects Of An Adapted Physical Training On Functional And Psycho-physical Status In Patients With Spinal Cord Injury 395
null 390
Efficacy of L-carnitine administration on fatigue, quality of life and nutritional status in 12 advanced cancer patients undergoing anticancer therapy 365
Randomised phase III clinical trial to evaluate the efficacy and safety of an integrated treatment (diet, pharmaco-nutrional and pharmacological) in cancer patients with cancer-related anorexia/cachexia and oxidative stress: interim results 365
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 357
null 342
null 304
null 267
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial 262
Randomised phase III clinical trial to evaluate the efficacy and safety of an integrated treatment (diet, pharmaco-nutritional and pharmacological) in cancer patients with cancer-related anorexia/cachexia and oxidative stress: Interim results 261
MESNA (2-mercaptoethane sulfonate) is effective in inducing lymphocyte progression through cell cycle in patients with advanced cancer of different sites 249
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 234
Impact of a two-drug combination regimen for cancer-related cachexia on nutritional, anabolic/metabolic, physical activity, anti-infammatory and quality of life variables 231
Curcuma Longa extract is effective in improving inflammatory status and redox balance in patients with cancer-related cachexia and oxidative stress 217
null 208
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 204
An innovative treatment approach for cancer-related anorexia/cachexia (CACS) and oxidative stress (OS). A phase III randomised clinical trial 152
null 147
An innovative treatment approach for cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 147
Prognostic role of lipid profile in patients with advanced cancer 144
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 102
Cancer related anorexia/cachexia and oxidative stress: A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 100
Focus on the assessment of physical activity level of patients with cancer cachexia enrolled in a randomized phase III clinical trial 92
Cancer-related anorexia/cachexia (CACS) and oxidative stress (OS): A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 88
Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia 80
Totale 105.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.496
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.135 0 0 0 0 0 0 2.757 601 323 350 334 770
2020/202125.096 725 866 827 6.976 5.608 2.916 2.334 1.545 579 1.152 1.027 541
2021/20224.262 401 314 179 296 465 341 175 187 353 439 550 562
2022/20235.508 491 659 689 447 465 528 254 459 355 379 464 318
2023/20246.816 445 336 335 511 693 1.312 839 473 311 467 584 510
2024/20257.135 1.040 1.647 1.329 1.267 700 1.116 36 0 0 0 0 0
Totale 105.606